|
YWHAG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.920600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.883000E-01 |
| Normal-vs-Stage2 |
8.180200E-01 |
| Normal-vs-Stage3 |
9.512800E-01 |
| Normal-vs-Stage4 |
8.919600E-01 |
| Stage1-vs-Stage2 |
9.724200E-01 |
| Stage1-vs-Stage3 |
7.030200E-01 |
| Stage1-vs-Stage4 |
6.554400E-01 |
| Stage2-vs-Stage3 |
7.510800E-01 |
| Stage2-vs-Stage4 |
7.209600E-01 |
| Stage3-vs-Stage4 |
9.357200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.846400E-01 |
| Normal-vs-AfricanAmerican |
2.826200E-01 |
| Normal-vs-Asian |
5.399200E-01 |
| Caucasian-vs-AfricanAmerican |
2.380400E-01 |
| Caucasian-vs-Asian |
3.882200E-01 |
| AfricanAmerican-vs-Asian |
9.297900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.364000E-01 |
| Normal-vs-Female |
9.907600E-01 |
| Male-vs-Female |
4.497400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.025200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.630400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.733800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.455400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.225800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.920600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.528600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.048800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.093200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.695200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.559000E-01 |
| Classical-VS-Follicular |
6.02779999999692E-05 |
| Classical-VS-Other |
1.915000E-01 |
| Classical-VS-Normal |
4.717400E-01 |
| Tall-VS-Follicular |
2.182400E-02 |
| Tall-VS-Other |
2.342200E-01 |
| Tall-VS-Normal |
4.022200E-01 |
| Follicular-VS-Other |
9.950600E-01 |
| Follicular-VS-Normal |
2.624400E-02 |
| Other-VS-Normal |
3.475400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.039000E-01 |
| Normal-vs-N1 |
8.475200E-01 |
| N0-vs-N1 |
3.331400E-01 |
|
|
